Prevalence of patent foramen ovale determined by transesophageal echocardiography in patients with cryptogenic stroke aged 55 years or older. Same as younger patients?
- PMID: 20196992
- DOI: 10.1016/s1885-5857(10)70064-5
Prevalence of patent foramen ovale determined by transesophageal echocardiography in patients with cryptogenic stroke aged 55 years or older. Same as younger patients?
Abstract
Introduction and objectives: To investigate the relationship between patent foramen ovale and cryptogenic stroke in patients aged > or =55 years.
Methods: This prospective study determined the presence of patent foramen ovale and atrial septal aneurysm using transesophageal echocardiography in 262 consecutive patients with a diagnosis of probable cryptogenic stroke. Data from 44 patients aged > or =55 years with cryptogenic stroke (Group A) were compared with those from two other groups: 194 patients aged <55 years with cryptogenic stroke (Group B) and 24 control patients aged > or =55 years with stroke of known origin, namely grade III-V aortic atheromatosis (Group C).
Results: The frequency of patent foramen ovale in Group A was similar to that in Group B (38% vs. 36%; P=.85) but significantly higher than that in Group C (38% vs. 8%; P=.029). The frequency of patent foramen ovale with concomitant atrial septal aneurysm was significantly higher in the study group (Group A) than in the control Group C (18% vs. 0; P=.039) and non-significantly higher than in Group B (18% vs. 11%; P=.11).
Conclusions: The frequency of patent foramen ovale alone or in association with atrial septal aneurysm in patients with cryptogenic stroke aged > or =55 years was similar to that in those aged <55 years, but higher than that in patients aged > or =55 years with stroke of atherosclerotic origin. These data suggest that paradoxical embolism could be a cause of stroke in both age groups.
Similar articles
-
Patent foramen ovale and cryptogenic stroke in older patients.N Engl J Med. 2007 Nov 29;357(22):2262-8. doi: 10.1056/NEJMoa071422. N Engl J Med. 2007. PMID: 18046029
-
Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.J Am Coll Cardiol. 2018 May 22;71(20):2335-2342. doi: 10.1016/j.jacc.2018.02.046. Epub 2018 Mar 12. J Am Coll Cardiol. 2018. PMID: 29544871 Clinical Trial.
-
Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography.Stroke. 1993 Dec;24(12):1865-73. doi: 10.1161/01.str.24.12.1865. Stroke. 1993. PMID: 8248969
-
Patent foramen ovale and cryptogenic stroke: a matter of age?Semin Thromb Hemost. 2009 Jul;35(5):505-14. doi: 10.1055/s-0029-1234146. Epub 2009 Sep 8. Semin Thromb Hemost. 2009. PMID: 19739041 Review.
-
Prevention of stroke in patients with patent foramen ovale.Int J Stroke. 2010 Apr;5(2):92-102. doi: 10.1111/j.1747-4949.2010.00413.x. Int J Stroke. 2010. PMID: 20446943 Review.
Cited by
-
Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review.Front Neurol. 2020 Apr 28;11:281. doi: 10.3389/fneur.2020.00281. eCollection 2020. Front Neurol. 2020. PMID: 32411074 Free PMC article. Review.
-
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.Circ Cardiovasc Imaging. 2014 Jan;7(1):125-31. doi: 10.1161/CIRCIMAGING.113.000807. Epub 2013 Nov 8. Circ Cardiovasc Imaging. 2014. PMID: 24214884 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical